Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ)
CNY 8.97
(0.56%)
CNY 8.97
(0.56%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 261.79 Million CNY | 689.9% |
| 2022 | 33.14 Million CNY | 22.56% |
| 2021 | 27.04 Million CNY | 92.96% |
| 2020 | 14.01 Million CNY | -50.0% |
| 2019 | 28.02 Million CNY | -71.97% |
| 2018 | 100 Million CNY | 100.0% |
| 2017 | 50 Million CNY | -16.67% |
| 2016 | 60 Million CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | -100.0% |
| 2011 | 3.7 Million CNY | -51.95% |
| 2010 | 7.7 Million CNY | 0.0% |
| 2009 | - CNY | -100.0% |
| 2008 | 27.05 Million CNY | -47.98% |
| 2007 | 52 Million CNY | -11.13% |
| 2006 | 58.51 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 5 Million CNY | -81.48% |
| 2024 Q2 | 257.14 Million CNY | 223.06% |
| 2024 Q1 | 79.59 Million CNY | -69.6% |
| 2023 Q4 | 261.79 Million CNY | 583.7% |
| 2023 FY | 261.79 Million CNY | 689.9% |
| 2023 Q1 | 28.01 Million CNY | -15.47% |
| 2023 Q2 | 33.89 Million CNY | 20.99% |
| 2023 Q3 | 38.29 Million CNY | 12.96% |
| 2022 Q1 | 26.05 Million CNY | -3.63% |
| 2022 Q2 | 28.52 Million CNY | 9.45% |
| 2022 FY | 33.14 Million CNY | 22.56% |
| 2022 Q4 | 33.14 Million CNY | 20.56% |
| 2022 Q3 | 27.49 Million CNY | -3.61% |
| 2021 FY | 27.04 Million CNY | 92.96% |
| 2021 Q1 | 35.42 Million CNY | 152.79% |
| 2021 Q2 | 22.98 Million CNY | -35.12% |
| 2021 Q3 | 22.18 Million CNY | -3.51% |
| 2021 Q4 | 27.04 Million CNY | 21.92% |
| 2020 FY | 14.01 Million CNY | -50.0% |
| 2020 Q3 | 14.01 Million CNY | -50.0% |
| 2020 Q4 | 14.01 Million CNY | 0.0% |
| 2020 Q1 | 28.02 Million CNY | 0.0% |
| 2020 Q2 | 28.02 Million CNY | 0.0% |
| 2019 FY | 28.02 Million CNY | -71.97% |
| 2019 Q4 | 28.02 Million CNY | -41.61% |
| 2019 Q3 | 48 Million CNY | -47.22% |
| 2019 Q2 | 90.94 Million CNY | 0.0% |
| 2019 Q1 | 90.94 Million CNY | -9.05% |
| 2018 Q2 | 80 Million CNY | 60.0% |
| 2018 Q4 | 100 Million CNY | 25.0% |
| 2018 Q3 | 80 Million CNY | 0.0% |
| 2018 FY | 100 Million CNY | 100.0% |
| 2018 Q1 | 50 Million CNY | 0.0% |
| 2017 Q1 | 50 Million CNY | -16.67% |
| 2017 FY | 50 Million CNY | -16.67% |
| 2017 Q2 | 50 Million CNY | 0.0% |
| 2017 Q4 | 50 Million CNY | 0.0% |
| 2017 Q3 | 50 Million CNY | 0.0% |
| 2016 FY | 60 Million CNY | 0.0% |
| 2016 Q2 | 115.26 Million CNY | 0.0% |
| 2016 Q4 | 60 Million CNY | -7.81% |
| 2016 Q3 | 65.08 Million CNY | -43.53% |
| 2016 Q1 | - CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2014 Q3 | 6 Million CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q4 | - CNY | -100.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2013 Q2 | - CNY | 0.0% |
| 2013 Q3 | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2012 Q3 | - CNY | 0.0% |
| 2012 Q1 | - CNY | -100.0% |
| 2012 FY | - CNY | -100.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2012 Q2 | - CNY | 0.0% |
| 2011 FY | 3.7 Million CNY | -51.95% |
| 2011 Q3 | 4.7 Million CNY | 0.0% |
| 2011 Q1 | 7.7 Million CNY | 0.0% |
| 2011 Q4 | 3.7 Million CNY | -21.28% |
| 2011 Q2 | 4.7 Million CNY | -38.96% |
| 2010 Q4 | 7.7 Million CNY | -28.04% |
| 2010 Q3 | 10.7 Million CNY | -17.69% |
| 2010 FY | 7.7 Million CNY | 0.0% |
| 2010 Q1 | - CNY | 0.0% |
| 2010 Q2 | 13 Million CNY | 0.0% |
| 2009 Q2 | 20.85 Million CNY | 0.0% |
| 2009 Q3 | 17 Million CNY | -18.47% |
| 2009 Q4 | - CNY | -100.0% |
| 2009 FY | - CNY | -100.0% |
| 2008 Q4 | 27.05 Million CNY | 0.0% |
| 2008 FY | 27.05 Million CNY | -47.98% |
| 2007 FY | 52 Million CNY | -11.13% |
| 2006 FY | 58.51 Million CNY | 0.0% |